Todd Hobbs
![Todd Hobbs Todd Hobbs](https://glp-1-based-therapeutics.com/wp-content/uploads/sites/933/2024/01/Todd-Hobbs-150x150.png)
Company: Diasome Pharmaceuticals
Job title: Chief Medical Officer
Seminars:
Oral Delivery of GLP-1 and other Incretins: Targeting both Hepatic and Peripheral Uptake to Improve Patient Outcomes 4:15 pm
Hepatic targeting of incretins in metabolic diseases – the importance of mimicking normal physiology Highlighting a novel oral delivery platform, hepatic directed vesicles (HDV) Reviewing the potential benefits of dual targeting for GLP-1 in both hepatic and peripheral uptakeRead more
day: Conference Day One